Ragunath Singaravelu
- Biophysics top 2%
- Cancer Research top 5%
- MicroRNA in disease regulation 13
- Hepatology top 5%
- Hepatitis C virus research 8
-
- interferon and immune responses 5
-
- RNA Interference and Gene Delivery 4
-
- Virus-based gene therapy research 5
-
- SARS-CoV-2 and COVID-19 Research 3
-
- CAR-T cell therapy research 3
-
- Endoplasmic Reticulum Stress and Disease 3
- Co-authors
- John Paul PezackiRodney K. LynDana C. DanielsonJessie A. BlakeDavid C. KennedyRodney S. RussellKatey J. RaynerNeda Nasheri
- Cited by
- BiophysicsCancer ResearchHepatology
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Ragunath Singaravelu
31 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 90
- Biophysics 165
- Cancer Research 425
- Hepatology 141
- Immunology 212
- Molecular Biology 668
Countries citing papers authored by Ragunath Singaravelu
This map shows the geographic impact of Ragunath Singaravelu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ragunath Singaravelu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ragunath Singaravelu more than expected).
Fields of papers citing papers by Ragunath Singaravelu
This network shows the impact of papers produced by Ragunath Singaravelu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ragunath Singaravelu. The network helps show where Ragunath Singaravelu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ragunath Singaravelu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2021 | 11 | |
| 3 | 2021 | 23 | |
| 4 | 2021 | 2 | |
| 5 | 2019 | 24 | |
| 6 | 2019 | 18 | |
| 7 | 2018 | 31 | |
| 8 | 2018 | 28 | |
| 9 | 2016 | 22 | |
| 10 | 2016 | 3 | |
| 11 | 2015 | 56 | |
| 12 | 2014 | 55 | |
| 13 | 2014 | 27 | |
| 14 | 2013 | 29 | |
| 15 | 2013 | 94 | |
| 16 | 2013 | 20 | |
| 17 | 2011 | 190 | |
| 18 | 2010 | 25 | |
| 19 | 2010 | 36 | |
| 20 | 2010 | 31 |
About Ragunath Singaravelu
Ragunath Singaravelu is a scholar working on Hepatology, Cancer Research and Virology, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Hepatitis C virus research (8 papers), interferon and immune responses (5 papers), Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), CAR-T cell therapy research (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). The work is most often cited by research in Biophysics (165 citations), Cancer Research (425 citations) and Hepatology (141 citations). Ragunath Singaravelu has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include John Paul Pezacki, Rodney K. Lyn, Dana C. Danielson, Jessie A. Blake, David C. Kennedy, Rodney S. Russell, Katey J. Rayner, Neda Nasheri, Prashanth Srinivasan and Mireille Ouimet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.